Chi Sheng Pharma & Biotech Co., Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 1,041.81 million compared to TWD 979.36 million a year ago. Revenue was TWD 1,041.81 million compared to TWD 979.36 million a year ago.

Net income was TWD 80.75 million compared to TWD 59.14 million a year ago. Basic earnings per share from continuing operations was TWD 1.42 compared to TWD 1.04 a year ago. Diluted earnings per share from continuing operations was TWD 1.41 compared to TWD 1.03 a year ago.